Cargando…

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Kuusanmäki, Heikki, Leppä, Aino-Maija, Pölönen, Petri, Kontro, Mika, Dufva, Olli, Deb, Debashish, Yadav, Bhagwan, Brück, Oscar, Kumar, Ashwini, Everaus, Hele, Gjertsen, Bjørn T., Heinäniemi, Merja, Porkka, Kimmo, Mustjoki, Satu, Heckman, Caroline A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2020
Materias:	Aticle
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049363/ https://www.ncbi.nlm.nih.gov/pubmed/31296572 http://dx.doi.org/10.3324/haematol.2018.214882

Ejemplares similares

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models
por: Han, Lina, et al.
Publicado: (2020)

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2023)

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
por: Bill, Marius, et al.
Publicado: (2020)

Case Report: Severe COVID-19 and Dengue in an Indonesian Infant
por: Alam, Anggraini, et al.
Publicado: (2021)

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
por: Malani, Disha, et al.
Publicado: (2022)

P409: BCL-2/BCL-XL INHIBITION INDUCES APOPTOSIS AND CIRCUMVENTS VENETOCLAX RESISTANCE IN TP53-MUTATED ACUTE MYELOID LEUKEMIA
por: Vänttinen, Ida, et al.
Publicado: (2023)

Human KIAA1018/FAN1 nuclease is a new mitotic substrate of APC/C(Cdh1)
por: Lai, Fenju, et al.
Publicado: (2012)

Health-related Quality of Life of Nurses Working in Tertiary Care Hospital of Karachi
por: Ali, Amjad, et al.
Publicado: (2020)

Epilepsy monitoring units in Saudi Arabia:: Where do we stand compared to developed countries?
por: Aljafen, Bandar N., et al.
Publicado: (2018)

Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2022)

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL
por: Laukkanen, S, et al.
Publicado: (2017)

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types
por: Majumder, Muntasir M., et al.
Publicado: (2020)

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling
por: Kuusanmäki, Heikki, et al.
Publicado: (2017)

Computational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints
por: Brummer, Otso, et al.
Publicado: (2023)

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
por: Pietarinen, Paavo O., et al.
Publicado: (2017)

Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease
por: Everaus, Hele
Publicado: (2014)

Closer to personalized approach through accepting the gender differences in medicine
por: Everaus, Hele
Publicado: (2014)

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells
por: Kreutzman, Anna, et al.
Publicado: (2014)

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing
por: Majumder, Muntasir Mamun, et al.
Publicado: (2017)

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids
por: Sak, Katrin, et al.
Publicado: (2017)

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
por: Pietarinen, P O, et al.
Publicado: (2015)

Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
por: Hohtari, Helena, et al.
Publicado: (2019)

P562: CAPILLARY BLOOD SAMPLING ALLOWS FEASIBLE METHOD FOR VENETOCLAX CONCENTRATION MEASUREMENT IN AN ACADEMIC MULTICENTER CLINICAL TRIAL CONTEXT
por: Kytölä, Sari, et al.
Publicado: (2023)

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
por: Adnan Awad, Shady, et al.
Publicado: (2020)

Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

Data-driven characterization of molecular phenotypes across heterogeneous sample collections
por: Mehtonen, Juha, et al.
Publicado: (2019)

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Genome-wide analysis of primary microRNA expression using H3K36me3 ChIP-seq data
por: Turunen, Tanja, et al.
Publicado: (2021)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
por: Eldfors, S, et al.
Publicado: (2017)

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2020)

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
por: Ilander, Mette, et al.
Publicado: (2014)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX.
por: Waclawiczek, Alexander, et al.
Publicado: (2023)

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
por: Ojamaa, Kristiina, et al.
Publicado: (2018)

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
por: Huuhtanen, Jani, et al.
Publicado: (2022)

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
por: El Missiry, Mohamed, et al.
Publicado: (2017)

An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia
por: Kong, Weikaixin, et al.
Publicado: (2022)

Exposure to bacterial and fungal bioaerosols in facilities processing biodegradable waste
por: Kontro, Merja H., et al.
Publicado: (2022)

P408: COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
por: Renders, Simon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bguo6fmiv52egk3urjhhs3pnus